Market Overview

TherapeuticsMD Up 40% After Mixed Q3, Plans To Resubmit NDA For TX-004HR


TherapeuticsMD Inc (NASDAQ: TXMD) shares are trading higher by $1.79 (39.8 percent) at $6.15 in Monday's session.

Before the open, the company reported a mixed Q3 report that beat for EPS but missed for sales by $8.1 million.

Investors appear to be encouraged by the news that the company plans to resubmit NDA for TX-004HR, for women with moderate-to-severs vaginal pain during intercourse.

After a higher, TherapeuticsMD retreated but immediately found support at $5.94 and continued its move higher. The ensuing rally took the stock to $6.85, which marks its highest level since it peaked on Sept. 7 at $7.01. Since reaching that level, it has been drifting back towards the low for the session, but has yet to make one as of 12:40 p.m. EST.

Posted-In: Earnings News Technicals Intraday Update Movers Trading Ideas


Related Articles (TXMD)

View Comments and Join the Discussion!

Semiconductor ETFs Surge On Broadcom Bid For Qualcomm

31 Stocks Moving In Monday's Mid-Day Session